Organon (OGN) Share-based Compensation (2020 - 2026)

Organon (OGN) has reported Share-based Compensation for 7 consecutive years, with $19.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation fell 20.83% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $72.0 million (down 30.1% YoY), while the FY2025 annual figure was $77.0 million, down 26.67% from the prior year.
• Share-based Compensation came in at $19.0 million for Q1 2026 at Organon, up from $7.0 million in the prior quarter.
• The five-year high for Share-based Compensation was $28.0 million in Q2 2024, with the low at $7.0 million in Q4 2025.
• Average Share-based Compensation over 5 years is $22.2 million, with a median of $24.0 million recorded in 2025.
• Across the five-year window, Share-based Compensation jumped 53.33% in 2022 and sank 73.08% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $23.0 million in 2022, then increased by 17.39% to $27.0 million in 2023, then slipped by 3.7% to $26.0 million in 2024, then plunged by 73.08% to $7.0 million in 2025, then soared by 171.43% to $19.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $19.0 million, $7.0 million, and $24.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.